Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

BACKGROUND: In chronic obstructive pulmonary disease (COPD), both the time needed for patients to gain symptom improvement with long-acting bronchodilator therapy and whether an early response is predictive of a sustained response is unknown. This study aimed to investigate how quickly meaningful sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Maltais, Francois, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, Bjermer, Leif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278094/
https://www.ncbi.nlm.nih.gov/pubmed/32462979
http://dx.doi.org/10.1177/1753466620926949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278094/
https://www.ncbi.nlm.nih.gov/pubmed/32462979
http://dx.doi.org/10.1177/1753466620926949

Ejemplares similares